← k veľkým investorom
Nextech Invest, Ltd.
inštitucionálny investor · portfólio $2.11 mld. · 16 pozícií · správa k 30.06.2026
Akciové Pozície správa za 30.06.2026, podaná 14.08.2026; zmena — oproti 31.03.2026 · 19
| Spoločnosť | Akcie | Hodnota | % portfólia | Zmena za Štvrťrok |
|---|---|---|---|---|
| Revolution Medicines, Inc. US:RVMD | 7 601 087 | $1.42 mld. | 67.55% | — |
| Parabilis Medicines, Inc. US:PBLS | 4 663 176 | $128 mil. | 6.06% | nová |
| Relay Therapeutics Inc US:RLAY | 6 776 506 | $127 mil. | 6.02% | +1 250 000 |
| Tyra Biosciences Inc US:TYRA | 3 553 585 | $114 mil. | 5.39% | −502 276 |
| Alumis Inc US:ALMS | 3 540 998 | $99.6 mil. | 4.73% | — |
| Oric Pharmaceuticals, Inc. US:ORIC | 7 162 637 | $77.6 mil. | 3.68% | — |
| Kymera Therapeutics Inc US:KYMR | 278 896 | $32.0 mil. | 1.52% | — |
| Zymeworks Inc. US:ZYME | 1 113 946 | $29.1 mil. | 1.38% | — |
| Monte Rosa Therapeutics Inc US:GLUE | 761 153 | $18.4 mil. | 0.87% | +456 916 |
| Arvinas Inc US:ARVN | 1 122 713 | $17.1 mil. | 0.81% | +583 319 |
| CytomX Therapeutics Inc US:CTMX | 4 449 932 | $16.7 mil. | 0.79% | — |
| Silence Therapeutics PLC US:SLN | 952 400 | $10.5 mil. | 0.50% | — |
| Corvus Pharmaceuticals Inc US:CRVS | 450 000 | $6.72 mil. | 0.32% | — |
| Context Therapeutics Inc US:CNTX | 7 419 355 | $4.11 mil. | 0.20% | — |
| enGene Therapeutics Inc. US:ENGN | 2 324 943 | $4.02 mil. | 0.19% | nová |
| Cullinan Therapeutics, Inc. US:CGEM | 0 (bolo 1 141 145) | — | — | predaná |
| ENGENE HOLDINGS INC CUSIP 29286M105 | 0 (bolo 2 324 943) | — | — | predaná |
| ARS Pharmaceuticals, Inc US:SPRY | 0 (bolo 610 703) | — | — | predaná |
| Tango Therapeutics, Inc. US:TNGX | 0 (bolo 7 266 081) | — | — | predaná |
V Spoločnostiach Našej Databázy 4
| Spoločnosť | Podiel | Akcie | Dátum Správy |
|---|---|---|---|
| Context Therapeutics Inc | 8.08% | 7 419 355 | 2026-06-30 |
| Revolution Medicines, Inc. | 3.55% | 7 601 087 | 2026-06-30 |
| enGene Therapeutics Inc. | 3.47% | 2 324 943 | 2026-06-30 |
| Silence Therapeutics PLC | 1.58% | 952 400 | 2026-06-30 |
reklama